Skip to main content
OpenTrials

Clinical trial condition

Pruritus

Explore clinical trials studying Pruritus. Study availability and eligibility vary by location and protocol.

331 public trials 35 recruiting studies
Refine in advanced search Browse all conditions

Pruritus trial results

Completed

A Study to Assess Immunization Responses in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Treated With Nemolizumab

NCT04365387

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +13 more
Locations
  • Galderma Investigational Site (Site#9922) Phoenix, Arizona, United States
  • Galderma Investigational Site (Site#8873) Scottsdale, Arizona, United States
  • Galderma Investigational Site (Site#8447) Fort Smith, Arkansas, United States
  • Galderma Investigational Site (Site#8831) Anaheim, California, United States
View all 64 locations
View Trial Details
Completed

Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial

NCT05590585

Conditions
Atopic Eczema, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +14 more
Locations
  • Total Skin & Beauty Dermatology Center Birmingham, Alabama, United States
  • The University Of Alabama At Birmingham Birmingham, Alabama, United States
  • C2 Research Center, LLC Montgomery, Alabama, United States
  • Center for Dermatology Clinical Research, inc. Fremont, California, United States
View all 30 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis

NCT06238817

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +14 more
Locations
  • Lynn Institute of the Ozarks Little Rock, Arkansas, United States
  • First Oc Dermatology Fountain Valley, California, United States
  • Center For Dermatology Cosmetic and Laser Surgery Fremont, California, United States
  • Medderm Associates, Inc San Diego, California, United States
View all 94 locations
View Trial Details
Completed

Comparison of Secukinumab 300 mg Combined With a Lifestyle Intervention to Secukinumab Alone for the Treatment of Moderate to Severe Psoriasis Patients With Concomitant Metabolic Syndrome

NCT03440736

Conditions
Body Weight, Diabetes Mellitus, Endocrine System Diseases, +20 more
Locations
  • Novartis Investigative Site Langenau, Baden-Wurttemberg, Germany
  • Novartis Investigative Site Munich, Bavaria, Germany
  • Novartis Investigative Site Munich, Bavaria, Germany
  • Novartis Investigative Site Darmstadt, Hesse, Germany
View all 75 locations
View Trial Details
Completed

Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria

NCT05936567

Conditions
Angioedema, Cardiovascular Diseases, Chronic Disease, +19 more
Locations
  • Clinical Research Center of Alabama Birmingham, Alabama, United States
  • Cahaba Dermatology Birmingham, Alabama, United States
  • Foothills Research Center Scottsdale, Arizona, United States
  • Little Rock Allergy Asthma, Pa Clinical Research Center Lraac Little Rock, Arkansas, United States
View all 42 locations
View Trial Details

Related conditions